Matinas BioPharma | Investor Presentation Deck | 31 slides · page 29 of 31
Matinas BioPharma | Investor Presentation Deck | 31 slides · slide 29
Pitch deck · unfair_advantage · present_solution · dense density
Slide locked Sign in to view
Slide schematic 7/7
callout 1/1 image 1/1 list 3/3 title 2/2
Components 7
primary icon-grid bullet bullet bullet action-title headline
Tools 2
Audience Definition slide · 70%
The slide appears to be focused on the company's intellectual property portfolio, suggesting that the audience is interested in understanding the company's assets and competitive advantage.
Call to action slide · 50%The title/action-title 'Continuing increasing our patent suite to increase protection and exclusivity' implies a call to action to continue expanding the patent suite.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.